| |
Dolutegravir Expanded Access Program Open Now
|
| |
| |
Dolutegravir is the new ViiV integrase inhibitor currently in phase 3 now. An Expanded Access Program has just been opened by ViiV.
The link to the dolutegravir web-site for more information is www.dolutegravir-eap.com/
| |
| |
| |
|
|
|
